Krishnendu Khan

Krishnendu Khan, Ph.D., serves as a Principal Scientist in Advanced Therapies at West Pharmaceutical Services since January 2023, focusing on assay development for patient-centric packaging solutions in gene and cell therapy. Prior to this role, Krishnendu Khan worked at Cleveland Clinic from December 2015 to January 2023 as an Innovations Engagement Manager in Life Sciences, enhancing researcher engagement and assessing the readiness of emerging technologies. Experience includes various positions at Cleveland Clinic, focusing on the impact of clinical mutations, protein translation, and technology transfer, as well as postdoctoral research at MPI-CBG and the Indian Institute of Science, where efforts centered on transcription regulation and protein characterization. Krishnendu Khan holds a Ph.D. in Biochemistry from the Indian Institute of Science and completed a B.Sc. in Microbiology at Delhi University.